Embecta closes Owen Mumford acquisition for up to $201M

Embecta closes Owen Mumford acquisition for up to $201M is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-05-18

Embecta acquired the company, which has an auto-injector platform, to expand outside of diabetes care.

Source: MedTech Dive